Nonmelanoma Skin Cancer
Commentary
Comment on “Skin Cancer Screening: The Paradox of Melanoma and Improved All-Cause Mortality”
I was unsurprised and gratified by the information presented in the Viewpoint on skin cancer screening by Ngo1 (Cutis. 2024;113:...
Latest News
The DEA Plans to Reschedule Marijuana: What Happens Next?
Following 2023 FDA information that legitimized marijuana as a medical treatment, DEA moves to lower its scheduling.
Military Dermatology
The Burden of Skin Cancer in the Military Health System, 2017-2022
This study evaluated the burden of skin cancer within the Military Health System (MHS), as demonstrated by the period prevalence of skin cancer...
Clinical Review
An Update on Cutaneous Angiosarcoma Diagnosis and Treatment
Dermatologists should be aware of challenges in diagnosing cutaneous angiosarcoma (CAS) due to its clinical similarity to benign entities such as...
Original Research
Recurrence Rates of Mohs Micrographic Surgery vs Radiation Therapy for Basal Cell Carcinoma of the Ear
Although Mohs micrographic surgery remains the gold standard for treating basal cell carcinoma of the ear, radiation therapy can be considered as...
Case Reports
The Clinical Utility of Teledermatology in Triaging and Diagnosing Skin Malignancies: Case Series
Teledermatology via store-and-forward technology has been demonstrated to be effective in assessing and triaging various cutaneous malignancies....
Photo Challenge
Chronic Cribriform Ulcerated Plaque on the Left Calf
A 61-year-old man presented to the dermatology clinic for evaluation of a painless nonhealing wound on the left calf of 4 years’ duration. The...
From the Journals
Few Cancer Survivors Meet ACS Nutrition, Exercise Guidelines
Researchers estimate more than 9,000 survivors’ adherence to weight, physical activity, fruit and vegetable consumption, and alcohol intake...
Latest News
Keratoacanthoma, SCC Relatively Rare With PD-1/PD-L1 Inhibitors, Study Suggests
Significant signals were reported for both keratoacanthoma and cSCC with PD-1/PD-L1 inhibitor use.
From the Journals
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Researchers assess validity of the molecular targets and clinical benefits of genome-targeted cancer drugs approved in the United States from 2015...
Conference Coverage
No Routine Cancer Screening Option? New MCED Tests May Help
CanScan, MERCURY, and OncoSeek can detect a range of cancers and recognize the tissue of origin with high accuracy.